Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return exceeding the market benchmark by more than 15% over the next 6-12 months [6]. Core Views - The company reported a significant improvement in net profit for Q1 2025, with a net profit of 0.65 billion yuan, a year-on-year increase of 69.24% and a quarter-on-quarter increase of 3.98 billion yuan [1][2]. - The company is experiencing a steady capacity expansion and has a complete industrial chain from fluorine resources to lithium battery production, which is expected to drive long-term growth [3][4]. - The company has increased its profit forecasts for 2025-2027, projecting net profits of 0.281 billion yuan (up 79.5%), 0.336 billion yuan (up 34.3%), and 0.446 billion yuan respectively [4]. Summary by Sections Financial Performance - In 2024, the company achieved an operating income of 8.207 billion yuan, a decrease of 31.25% year-on-year, and a net profit attributable to shareholders of -0.308 billion yuan, down by 8.18 billion yuan [1][2]. - The Q1 2025 operating income was 2.098 billion yuan, a decrease of 2.09% year-on-year but an increase of 57.68% quarter-on-quarter [1]. Revenue Breakdown - In 2024, the revenue from various segments was as follows: fluorine-based new materials (2.693 billion yuan, +20.42%), electronic information materials (0.935 billion yuan, -24.52%), new energy materials (2.593 billion yuan, -45.93%), and new energy batteries (1.611 billion yuan, -38.33%) [2]. Capacity Expansion - The company has a total existing capacity of 330,000 tons/year for anhydrous aluminum fluoride, 65,000 tons/year for lithium hexafluorophosphate, and 60,000 tons/year for electronic-grade hydrofluoric acid, with several projects under construction [3]. Research and Development - The company is increasing its R&D investment in the lithium battery sector, focusing on safety and efficiency improvements in its products, which are gaining traction in various applications [4]. Profit Forecasts - The company has adjusted its profit forecasts for 2025-2027, with expected net profits of 0.281 billion yuan, 0.336 billion yuan, and 0.446 billion yuan respectively, indicating a positive outlook for future profitability [4][5].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [6]. Core Views - The company experienced significant revenue decline in 2024, with total revenue of 8.207 billion yuan, a year-on-year decrease of 31.25%. The net profit attributable to shareholders was -308 million yuan, down 160.36% year-on-year [1][5]. - In Q1 2025, the company reported a revenue of 2.098 billion yuan, a slight decrease of 2.09% year-on-year, but a net profit of 65 million yuan, representing a 69.24% increase year-on-year [1]. - The company’s four major business segments are showing collaborative growth, particularly in lithium hexafluorophosphate, which saw sales of 4.33 tons and revenue of 2.593 billion yuan in 2024, accounting for 31.59% of total revenue [3]. Summary by Sections Financial Performance - In Q4 2024, the company reported a revenue of 1.331 billion yuan, a decrease of 57.78% year-on-year, and a net profit of -333 million yuan, turning from profit to loss compared to Q4 2023 [2]. - The gross margin for Q4 2024 was 10.88%, a decrease of 0.23 percentage points year-on-year, while the net margin was -38.65%, down 40 percentage points year-on-year [2]. Business Segments - The revenue breakdown for 2024 shows that fluorine-based new materials generated 2.693 billion yuan (32.81% of total revenue), electronic information materials contributed 935 million yuan (11.39%), and new energy batteries accounted for 1.611 billion yuan (19.63%) [3]. - The company has established a clear capacity layout, with an annual production capacity of 60,000 tons of electronic-grade hydrofluoric acid and ongoing expansion in various fields [3]. Future Outlook - The company is projected to achieve revenues of 10.742 billion yuan, 13.408 billion yuan, and 16.190 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 30.9%, 24.8%, and 20.8% [4][5]. - The net profit attributable to shareholders is expected to recover to 290 million yuan in 2025, with significant growth anticipated in subsequent years [4][5].

证券代码：002407 证券简称：多氟多 多氟多新材料股份有限公司 投资者关系活动记录表 编号：20250424 投资者关系 活动类别 □特定对象调研 □分析师会议 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他（电话会议） 参与单位名称 及人员姓名 投资者网上提问 时间 2025 年 4 月 24 日 15:00-16:30 地点 全景网"投资者关系互动平台"（https://ir.p5w.net） 上市公司接待 人员姓名 李云峰 总经理 程立静 副总经理、财务总监 梁丽娟 独立董事 彭 超 董事会秘书 投资者关系活动 主要内容介绍 本次业绩说明会分为三个部分：第一部分为公司董事长李世江 及新能源电池版块负责人许飞接受全景网的采访；第二部分为公司 2024 年度与 2025 年一季度经营业绩介绍；第三部分为交流互动环 节。 一、采访展播 公司董事长李世江及新能源电池版块负责人许飞接受全景网采 访，就投资者普遍关注问题进行回答，详见全景路演·多氟多 2024 年度业绩说明会（https://rs.p5w.net/html/145972.shtml）。 二、公司经营业绩 2024 年，公 ...

Core Viewpoint - The company, Duofluor, is establishing a unique competitive advantage in the rapidly growing Chinese new energy industry by integrating fluorine, lithium, silicon, and boron materials with solid-state battery technology, showcasing a narrative of "counter-cyclical growth" through technological iteration, cost control, and long-term strategies [1][8]. Group 1: Company Overview - Duofluor, founded in December 1999 and listed in May 2010, has evolved from a focus on inorganic fluorides to a diversified business model spanning traditional industries, new energy, and semiconductors, forming a "basic materials + high-end applications" driving model [2][3]. - The company operates four main business segments: fluorine-based new materials, electronic information materials, new energy materials, and new energy batteries, all achieving significant market positions [3]. Group 2: Product and Technology Development - The fluorine-based new materials segment includes products like anhydrous aluminum fluoride and anhydrous hydrogen fluoride, with the production process for anhydrous aluminum fluoride being a third-generation technology that has reached an international leading level [3]. - The electronic information materials segment produces electronic-grade hydrogen fluoride, which has successfully entered the semiconductor supply chain, with an annual production capacity of 60,000 tons [4]. - In the new energy materials segment, the company has a production capacity of 65,000 tons of high-purity crystalline lithium hexafluorophosphate (LiPF6), which is a key component in lithium battery electrolytes, and is positioned among the top global producers [5]. Group 3: Market Trends and Future Outlook - The demand for sodium-ion batteries is expected to grow significantly, with projections indicating a market demand of 520 GWh by 2030, presenting a market opportunity exceeding 200 billion [5]. - The company is also advancing in solid-state battery materials, having developed patents for polymer and oxide solid-state electrolytes, with ongoing internal testing and a pilot production line established [7]. - The company’s comprehensive supply chain from fluorine resources to lithium batteries positions it well for future growth, especially as the global demand for lithium batteries is expected to stabilize and grow [8][13]. Group 4: Financial Performance and Strategic Moves - In 2024, the company faced a net loss due to asset impairment and declining product prices, but excluding these factors, it did not incur a net loss, indicating resilience [9][11]. - In Q1 2025, the company reported a revenue of 2.098 billion, with a net profit of 64.73 million, reflecting a significant year-on-year increase of 69.24%, showcasing effective cost control [11]. - The company has initiated a share buyback program, indicating confidence in its future performance and commitment to enhancing shareholder value [15]. Group 5: Industry Context and Competitive Landscape - The fluorochemical industry is positioned for growth due to increasing environmental regulations and the push for sustainable development, which aligns with the company's focus on innovation and eco-friendly products [12]. - The electronic information materials sector is experiencing rising demand driven by advancements in technology, with domestic companies like Duofluor poised to benefit from reduced reliance on imports [13]. - The new energy vehicle market is projected to grow significantly, with production and sales expected to exceed 10 million units in 2024, further driving demand for the company's products [14].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002407 证券简称：多氟多 公告编号：2025-036 一、重要提示 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者 应当到证监会指定媒体仔细阅读年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 √适用 □不适用 是否以公积金转增股本 □是 √否 公司经本次董事会审议通过的利润分配预案为：以1,160,507,098股为基数，向全体股东每10股派发现金 红利2元（含税），送红股0股（含税），不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 1、公司简介 ■ 2、报告期主要业务或产品简介 公司主要从事高性能无机氟化物、电子信息材料、锂离子电池及材料等领域的研发、生产和销售。 （1）氟基新材料 ①主要产品简介及用途 报告期内公司氟基新材料主要产品包括：无水氟化铝、高分子比冰晶石、无水氟化氢等。 氟化铝、冰晶石作为助熔剂能够有效降低电解铝过程中电解质的熔化温度 ...

（原标题：多氟多2024年度拟派2.32亿元红包） 4月23日多氟多发布2024年度分配预案，拟10派2元（含税），预计派现金额合计为2.32亿元。这是公司上市以来，累计第16次派现。 公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2024.12.31 | 10派2元（含税） | 2.32 | 1.51 | | 2023.12.31 | 10派3元（含税） | 3.51 | 1.27 | | 2022.12.31 10转增4派6元（含税） | | 4.58 | 1.44 | | 2021.12.31 | 10派3元（含税） | 2.29 | 0.78 | | 2021.06.30 | 10派2元（含税） | 1.53 | 0.79 | | 2019.12.31 | 10派0.1元（含税） | 0.07 | 0.07 | | 2018.12.31 | 10派2元（含税） | 1.37 | 1.34 | | 2018.06.30 | 10派1.5元（含税） | 1.05 | 0.84 | | 2017. ...

证券代码：002407 证券简称：多氟多 公告编号：2025-037 多氟多新材料股份有限公司 关于2024年度计提资产减值准备、资产处置和往来核销的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 多氟多新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日召开第 七届董事会第二十八次会议，审议通过了《2024 年度计提资产减值准备、资产处置 和往来核销的议案》，同意公司进行 2024 年度资产减值准备计提、固定资产处置， 对长期挂账的往来款项进行核销。具体情况如下： 一、资产减值准备情况 （一）本次计提资产减值准备的原因 为公允地反映公司截至 2024 年 12 月 31 日的财务状况及 2024 年度的经营成果， 根据《企业会计准则》和相关会计政策的规定，公司及控股子公司对各项资产进行 了全面充分的清查、分析和评估，对可能发生价值减损的资产计提减值准备。 （二）本次计提资产减值准备的资产范围、总金额和计入的报告期间 公司可能发生价值减损的资产范围：包括应收账款、应收票据、其他应收款、 存货、固定资产等。2024 年共计提减值损失 ...

证券代码：002407 证券简称：多氟多 公告编号：2025-034 多氟多新材料股份有限公司 2024年募集资金存放与使用情况专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，不存在虚 假记载、误导性陈述或者重大遗漏。 一、 募集资金基本情况 （一）2021 年定向增发募集资金基本情况 经中国证券监督管理委员会证监许可[2021]313 号文《关于核准多氟多化工股份有限公 司非公开发行股票的批复》核准，多氟多新材料股份有限公司（以下简称"公司"或"本公 司"）由主承销商中原证券股份有限公司于 2021 年 4 月 13 日向特定投资者定向发行人民币 普通股（A 股）69,277,108 股，每股面值人民币 1 元，每股发行认购价格为人民币 16.60 元。 截至 2021 年 4 月 28 日止，公司共计募集货币资金人民币 1,149,999,992.80 元，扣除与发行 有关的费用人民币 8,618,634.26 元，实际募集资金净额为人民币 1,141,381,358.54 元。 截至 2021 年 4 月 28 日，公司上述发行募集的资金已全部到位，经大华会计师事务所（特 殊普通合伙 ...

多氟多新材料股份有限公司 2024年度内部控制自我评价报告 公司内部控制的目标是：保证公司经营管理合法合规；财务报告及相关信息真 实完整；资产安全完整；提高经营效率和效果；促进公司稳步可持续发展和发展战 略的实现。由于内部控制存在固有局限性，故公司的内部控制体系仅能对实现上述目 标提供合理保证而非绝对保证。此外，由于情况的变化可能导致内部控制变得不恰当， 会对控制政策和程序遵循程度降低，根据内部控制评价结果推测未来内部控制的有效 性具有一定的风险。 二、内部控制有效性的结论 根据公司财务报告内部控制重大缺陷的认定情况，于内部控制评价报告基准 日，不存在财务报告内部控制重大缺陷，董事会认为，公司已按照企业内部控制规 范体系和相关规定的要求在所有重大方面保持了有效的财务报告内部控制。 根据公司非财务报告内部控制重大缺陷认定情况，于内部控制评价报告基准 日，公司未发现非财务报告内部控制重大缺陷。 自内部控制评价报告基准日至内部控制评价报告发出日之间未发生影响内部 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管的要 求（以下简称"企业内部控制规范体系"），结合多氟多新材料股份有限公司（以 下简称"公 ...

多氟多新材料股份有限公司 2024年度监事会工作报告 二〇二五年四月 多氟多新材料股份有限公司 2024 年度监事会工作报告 多氟多新材料股份有限公司 2024 年度监事会工作报告 报告期内，多氟多新材料股份有限公司（以下简称"多氟多"或"公司"） 全体监事按照《中华人民共和国公司法》《中华人民共和国证券法》等有关法律 法规及《公司章程》《监事会议事规则》的相关要求，结合公司实际情况充分运 用监督职权，有效实现对公司财务、内部控制、信息披露、重大事项的监督，以 保护公司、股东、职工及其他利益相关者的合法权益。监事会成员通过列席和出 席董事会、总经理办公会及股东大会，了解熟悉公司经营目标及重要决策、生产 经营情况及财务状况，并对公司董事、总经理和其他高级管理人员的履职情况进 行了必要的监督检查，促进企业规范运作。 一、监事会参加会议及审议议案情况 各监事按照法律法规及监管要求，忠实勤勉、尽职履责，积极召开会议审 议议案、参加股东大会、列席董事会会议。 （一）2024 年度，监事会成员参加公司股东大会 4 次，详细了解会议议案 并依法对股东大会召开程序及股东表决情况进行监督。 （二）2024 年度，监事会成员列席 ...